General Cognition Research Articles

Clinical Manifestations.

The capacity to handle money and personal finances is crucial for living independently. Cognitive decline can lead to financial mismanagement (e.g., forgetting to pay bills, overspending) and exploitation (e.g., falling for financial scams). While greater susceptibility to financial mismanagement and exploitation is commonly reported by carers of people with dementia, objective neuropsychological measures of these financial skills are scarce. It is also unclear whether profiles of change in financial skills vary across different stages and subtypes of dementia. A normative sample of 112 healthy controls and individuals with mild cognitive impairment (MCI; n = 16), Alzheimer's disease (AD; n = 7) or behavioural-variant frontotemporal dementia (bvFTD; n = 18) completed a novel neuropsychological Test of Financial Skills (TOFS), which assessed performance across three key areas: everyday financial tasks, susceptibility to financial scams and financial goal planning. For all patients and controls, measures of dementia severity (Clinical Dementia Rating Scale) and general cognition (Addenbrooke's Cognitive Examination, 3rd Ed.) were also collected. Relative to controls, AD and bvFTD patients showed lower overall performance on the TOFS, whereas MCI patients did not differ significantly from controls. While AD and bvFTD patients showed similar levels of impairment on everyday financial tasks and financial goal planning, bvFTD patients performed significantly worse on the financial scams subtest. Across all participants, lower TOFS performance was associated with greater dementia severity and cognitive impairment. Our results are consistent with previous studies of carer-reported changes in financial mismanagement and exploitation in people with dementia. Notably, we found important differences in the areas of financial skills impacted by different stages and subtypes of dementia. These findings provide novel insights into the different factors that contribute to deficits in financial skills in people with dementia, highlight the importance of objective neuropsychological assessments in this area, and open avenues for targeted financial support strategies.

Plasma glial fibrillary acidic protein mediated the association of midlife pulmonary function and cognition in later‐life: A causal mediation analysis in a longitudinal population‐based cohort

AbstractBackgroundEpidemiological evidence indicates that poorer pulmonary function (PF) may be linked to faster cognitive decline and a greater risk of dementia. Inflammation is one possible mediator between poor PF and cognitive decline. Plasma glial fibrillary acidic protein (GFAP,) as a marker of neurodegeneration and inflammation, may mediate the association of poor PF to poor cognitive function. The APOE ε4 is a marker of Alzheimer’s disease (AD) genetic susceptibility and may modify the PF‐cognition association with mediating factors. We aimed to prospectively examine whether GFAP mediates the association of mid‐life PF with cognition and whether the mediation effects differ by APOE ε4 carriership.MethodWe studied 1,001 participants (average midlife age of 50.5 years, 45% men) in the Age, Gene/Environment Susceptibility‐Reykjavik Study with midlife PF measures [forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC)] and blood draw and cognition measured on average 23 years later. Plasma GFAP levels were assayed using a Simoa HD‐1 analyzer. A general cognition score was created by principle component analysis using multiple cognitive tests. Causal mediation regression models were constructed to estimate GFAP’s mediation effect on the association between mid‐life PF and cognitive function in later life. Analyses were stratified by APOE ε4 status (yes/no). Models were adjusted for age, sex, education, smoking, BMI, and estimated glomerular filtration rate.ResultLow midlife FEV1 and FVC were related to poor general cognition in later life [β = 0.44 (95% CI = 0.28, 0.62) and β = 0.38 (95% CI = 0.22, 0.54), respectively]. Higher PF was associated with lower plasma GFAP levels. The proportion of the association between FEV1 on cognition mediated by plasma GFAP was 4.4% (95% CI = 1.0%–10.0%), and between FVC and cognition was 4.9% (95% CI = 0.8%–14.6%). The mediation effect was greater in the APOE‐ε4 allele carriers [14.4% (95% CI = 0.04%–60.9%) and 14.6% (95% CI = 1.0%–54.5%) for FEV1 and FVC, respectively].ConclusionLow PF in midlife may increase the risk for later cognitive problems. This study suggests poor PF may contribute to neuroinflammation (as measured by GFAP) over the long term, especially in individuals at genetic risk of AD.

Clinical Variables Contributing to Identification of Mild Cognitive Impairment Individuals With Defined ATN Profile

AbstractBackgroundThe framework globally used to classify Alzheimer’s Disease stages for research purposes includes three core biomarkers: A) Aβ burden; T) tau pathology; and N) neuronal injury. A lack of consensus exists in linking cognitive and behavioral tests used in everyday clinical practice to biological stages of dementia as defined by the ATN classification. The aim of the current study is to identify the clinical variables that best classify individuals into biologically defined cognitive profiles.MethodA total of 751 subjects, from the Alzheimer’s Disease Neuroimaging Initiative cohort, were categorized into seven ATN groups: 112 cognitively unimpaired with ATN‐; 46 cognitively unimpaired with ATN or AT+; 65 cognitively unimpaired with T, N or TN+; 128 amnestic Mild Cognitive Impairment (aMCI) with ATN‐; 223 aMCI with ATN or AT+; 94 aMCI with T, N or TN+ and 83 dementia with ATN or AT+. The groups for which the features exhibited differences during data exploration were classified employing 28 cognitive, behavioral, and demographic features using a supervised machine learning algorithm, specifically, a random forest classifier in combination with a synthetic oversampling technique.ResultWe found that the selected features were not able to distinguish between all seven groups and in particular between the three cognitively unimpaired groups. Therefore, classification was only performed for the three ATN‐defined aMCI groups achieving 58% overall accuracy. The Logical Delayed Recall was the most relevant feature (explaining 17% of the variance), followed by the Alzheimer’s Disease Assessment Scale‐Cognitive Subscale 13 (16%), Everyday Cognition Informant (8%), and Alzheimer’s Disease Assessment Scale 4 (8%). Marital status, Everyday Cognition Patient and sex were not relevant (0%).ConclusionCognitive and behavioral tests were not able to accurately distinguish cognitively unimpaired individuals with different biological profiles. Although accuracy could be improved, our first results showed that a test of delayed memory, one of general cognition, and one on activities of daily living are relevant variables for distinguishing between patients with aMCI and different biological profiles. During diagnosis, treatment monitoring, or in research contexts, these variables might be informative in differentiating the three ATN‐defined aMCI profiles, especially when biomarkers are not available.

A neuropsychological investigation of social‐semantic knowledge in frontotemporal dementia

AbstractBackgroundThe loss of semantic memory is a key feature of frontotemporal dementia (FTD), and is associated with atrophy of the anterior temporal lobes (ATLs). The role of the left and right ATLs in supporting social‐semantic knowledge is unclear. To address this, we developed a social‐semantic battery comprising exemplars of social concepts such as person‐specific knowledge, abstract social concepts, and understanding of social norms. Performance on this battery was directly compared with non‐social semantic knowledge, measured using the Cambridge Semantic Test Battery.Method48 people with FTD (behavioural‐variant FTD = 26, semantic dementia = 22), and 19 age‐matched healthy controls were recruited. Participants completed both semantic batteries, alongside tests of general cognition and executive function. Participants also underwent a 3T T1‐weighted structural MRI scan. All neuropsychological tasks were entered into a principal component analysis (with varimax rotation) to explore graded variations in cognitive performance in FTD. Voxel‐based morphometry was conducted to explore grey matter correlates of social and non‐social semantic knowledge. The relative contributions of the left and right ATL to social‐semantic knowledge were tested by including ATL volume and asymmetry indices as predictors in a multiple regression analysis.ResultPeople with SD and bvFTD were impaired in both social‐and non‐social knowledge tasks. The principal component analysis indicated separate components for semantic memory and executive function. Both social and non‐social semantic tasks loaded onto the semantic memory component (Figure 1). People with SD scored significantly worse than bvFTD on the semantic memory component (t = 5.18, p<0.0001), while people with bvFTD scored worse than SD on the executive function component (t = 3.97, p<0.001) (Figure 2). Semantic memory factor scores were correlated with grey matter in the bilateral ATLs (Figure 3). There were no significant clusters associated with scores on the executive function component. Multiple regression revealed that performance on the semantic memory component was predicted by the magnitude but not the asymmetry of ATL atrophy.ConclusionBoth social and non‐social forms of semantic knowledge are impaired by FTD, and this degradation is associated with bilateral ATL atrophy. These results suggest a shared representation for all types of semantic memory across the ATLs.

Polymorphisms in the choline transporter SLC44A1 are associated with reduced cognitive performance in normotypic but not prenatal alcohol-exposed children

BackgroundCholine is essential for healthy cognitive development. Single nucleotide polymorphisms (SNPs; rs3199966(G), rs2771040(G)) within the choline transporter SLC44A1 increase risk for choline deficiency. In a choline intervention trial of children who experienced prenatal alcohol exposure (PAE), these alleles are associated with improved cognition. ObjectiveThis study aimed to determine if SNPs within SLC44A1 are differentially associated with cognition in children with PAE compared with normotypic controls (genotype × exposure). A secondary objective tested for an association of these SNPs and cognition in controls (genotype-only). DesignThis is a secondary analysis of data from the Collaborative Initiative on Fetal Alcohol Spectrum Disorders. Participants (163 normotypic controls, 162 PAE) underwent psychological assessments and were genotyped within SLC44A1. Choline status was not assessed. Association analysis between genotype × exposure was performed using an additive genetic model and linear regression to identify the allelic effect. The primary outcome was the interaction between SLC44A1 genotype × exposure status with respect to cognition. The secondary outcome was the cognitive–genotype association in normotypic controls. ResultsGenotype × exposure analysis identified 7 SNPs in SLC44A1, including rs3199966(G) and rs2771040(G), and in strong linkage (D′ ≥ 0.87), that were associated (adjusted P ≤ 0.05) with reduced performance in measures of general cognition, nonverbal and quantitative reasoning, memory, and executive function (β, 1.92–3.91). In controls, carriers of rs3199966(GT or GG) had worsened cognitive performance than rs3199966(TT) carriers (β, 0.46–0.83; P < 0.0001), whereas cognitive performance did not differ by rs3199966 genotype in those with PAE. ConclusionsTwo functional alleles that increase vulnerability to choline deficiency, rs3199966(G) (Ser644Ala) and rs2771040(G) (3′ untranslated region), are associated with worsened cognition in otherwise normotypic children. These alleles were previously associated with greater cognitive improvement in children with PAE who received supplemental choline. The findings endorse that choline benefits cognitive development in normotypic children and those with PAE.

Impairment of daily occupations in multiple sclerosis: analysis of neuroimaging, general and social cognition, and reserve

BackgroundMultiple Sclerosis (MS) can impact performance of daily occupations in both relapsing-remitting (RRMS) and secondary-progressive (SPMS) clinical courses. Work force participation decreases with advancing physical disability but the influence of non-motor factors, neuroimaging, and reserve have been scarcely investigated. We aimed to evaluate MRI, clinical, and cognitive (social and general) factors associated with impairment in different daily occupations and address whether cognitive and brain reserve have a positive impact on the ability to maintain these activities. MethodsWe prospectively enrolled persons with MS (PwMS) who underwent clinical examination (Expanded Disability Status Scale – EDSS; Timed 25-Foot Walk Test - T25FW; and the Nine Hole Peg Test - 9HPT), general neuropsychological assessment (Brief Repeatable Battery of Neuropsychological Tests – BRBN, including the Symbol Digit Modalities Test - SDMT), social cognition evaluation (Reading the Mind in the Eyes Test), cognitive reserve questionnaire, and MRI (FreeSurfer). We also enrolled healthy subjects for comparison as a control group. Daily occupations (employment, money management, and driving abilities) were assessed in all individuals with questionnaires. ResultsWe included 62 PwMS (32 RRMS and 30 SPMS; mean age 42.8 years; median educational time 12.75 years) and 67 controls (mean age 39.7; median educational time 12.0 years) which were similar regarding demographics, education, and socioeconomic status (p > 0.1). Most PwMS (67.7%) had work-restrictions. They also reported fewer money management and driving abilities than controls (p < 0.001). Work-restriction was associated with physical disability (p = 0.006), SDMT and BRBN performance (p = 0.035 and p = 0.031, respectively), and T2-lesion volume (p = 0.022), with large effect sizes (d > 0.75). After hierarchical linear regression, money management was associated with hand dexterity, general and social cognition, and cognitive reserve (p < 0.03). Variables associated with driving abilities included fatigue, verbal fluency, striatum volume, and brain reserve (p < 0.05). ConclusionsPwMS have more frequent work-restrictions and impairment in money management and driving abilities compared to controls. Cognitive function, physical disability, and MS-lesion burden are strongly associated with work-restriction. Social cognition can also influence financial capacity. Cognitive and brain reserve can help retain some of these daily occupations.

A longitudinal study of polygenic score and cognitive function decline considering baseline cognitive function, lifestyle behaviors, and diabetes among middle-aged and older US adults

BackgroundGenomic study of cognition decline while considering baseline cognition and lifestyle behaviors is scarce. We aimed to evaluate the impact of a polygenic score for general cognition on cognition decline rate, while considering baseline cognition and lifestyle behaviors, among the general population and people with diabetes, a patient group commonly affected by cognition impairment.MethodsWe tested associations of the polygenic score for general cognition with annual changing rates of cognition measures in 8 years of follow-up among 12,090 White and 3100 Black participants of the Health and Retirement Study (HRS), a nationally representative sample of adults aged 50 years and older in the USA. Cognition measures including word recall, mental status, and total cognitive score were measured biannually. To maximize sample size and length of follow-up, we treated the 2010 wave of survey as baseline, and follow-up data until 2018 were analyzed. Baseline lifestyle behaviors, APOE status, and measured cognition were sequentially adjusted. Given racial differences in polygenic score, all analyses were conducted by race.ResultsThe polygenic score was significantly associated with annual changing rates of all cognition measures independent of lifestyle behaviors and APOE status. Together with age and sex, the polygenic score explained 29.9%, 15.9%, and 26.5% variances of annual changing rates of word recall, mental status, and total cognitive scores among Whites and explained 17.2%, 13.9%, and 18.7% variance of the three traits among Blacks. Among both White and Black participants, those in the top quartile of polygenic score had the three cognition measures increased annually, while those in the bottom quartile had the three cognition measures decreased annually. After further adjusting for the average cognition assessed in 3 visits around baseline, the polygenic score was still positively associated with annual changing rates of all cognition measures for White (P ≤ 2.89E − 19) but not for Black (P ≥ 0.07) participants. In addition, among participants with diabetes, physical activity offset the genetic susceptibility to decline of mental status (interaction P ≤ 0.01) and total cognitive scores (interaction P = 0.03).ConclusionsPolygenic score predicted cognition changes in addition to measured cognition. Physical activity offset genetic risk for cognition decline among diabetes patients.

Associative learning and facial expression recognition in schizophrenic patients: Effects of social presence

Schizophrenia (SCZ) is a psychiatric disorder that alters both general and social cognition. However, the exact mechanisms that are altered remain to be elucidated. In this study, we investigated associative learning (AL) and facial expression recognition (FER) in the same patients, using emotional expressions and abstract images. Our main aim was to investigate how these cognitive abilities are affected by SCZ and to assess the role of mere social presence, a factor that has not been considered before. The study compared the behavioral performance of 60 treated outpatients with SCZ and 103 demographically matched healthy volunteers. In the AL task, participants had to associate abstract images or facial expressions with key presses, guided by feedback on each trial. In the FER task, they had to report whether two successively presented facial expressions were the same or different. All participants performed the two tasks under two social context conditions: alone or in the presence of a passive but attentive audience. The results showed a severe learning impairment in patients compared to controls, with a slight advantage for facial expressions compared to abstract images, and a gender-dependent effect of social presence. In contrast, facial expression recognition was partially spared in patients and facilitated by social presence. We conclude that cognitive abilities are impaired in patients with SCZ, but their investigation needs to take into account the social context in which they are assessed.

9 The Relationship Between Depressive Mood and Mini Mental Status Examination Scores in Individuals with Heart Failure

Objective:Heart failure occurs when the heart is unable to support a flow of blood that meets the body’s needs, ultimately resulting in decreased oxygenation throughout the body— including the brain. Results of previous research suggest that individuals with heart failure exhibit both localized and diffuse neuropsychological deficits. The aims of this study are to meta-analytically examine a) the performance of participants with heart-failure and healthy controls on the Mini Mental State Examination (MMSE), a neuropsychological test of general cognition, and b) the role of depressive mood as a potential moderator of performance on the MMSE in these participants.Participants and Methods:Two researchers independently searched eight databases for articles that examined the neuropsychological functioning of patients with heart failure.Inclusion criteria identified studies that had a heart failure group with a comparable control group and reported on neuropsychological assessment for both groups. Studies were excluded if a heart failure group had any other type of major organ failure or if the comparison was between different classes of heart failure rather than between a heart failure group and healthy controls.Results:A meta-analysis using a random-effects model revealed a statistically significant and large effect size estimate (g= 0.727, p &lt;.001) CI [.331, 1.123]. The heterogeneity was found to be statistically significant and in the large range, I2 = 83.027%, tau2 = .155, p &lt; .001. A meta-regression analyzing the relationship between depressive mood and MMSE effect size estimates was statistically significant, Q residual = 8.715, df = 3, p = .03.Conclusions:This study is the first to examine the relationship between depressive mood and general cognitive status (as measured by the MMSE) in participants with heart failure. The strong relationship between cognitive status and heart failure, and the role of depression in explaining a statistically significant portion of the heterogeneity in the relationship seen in primary studies, highlights the importance of accurately assessing depression when studying the effect of heart failure on cognition. Further research needs to examine the impact of depression on quality of life in patients with heart failure as potentially mediated by difficulties in cognition.

The emergence of language in the human mind and brain-Insights from the neurobiology of language, thought and action.

The capacity for language has evolved remarkably quickly in recent human history. Its advent likely coincided with a range of cognitive innovations not found elsewhere at this level of complexity in the rest of the animal kingdom. This late yet near-simultaneous florescence of higher language and cognition is difficult to account for in terms of strictly modular neurocognitive systems, each with its own dedicated function and evolutionary trajectory. Nor does it legitimize the neurocognitive study of language in isolation from other systems of human thought and action. In the wake of emergentist approaches to key human cognitive abilities, the present article considers language as the differentiated product of multiple neural networks dedicated to qualitatively distinct cognitive functions-including (at least) the cortical systems of general semantic cognition and control and the sensorimotor systems supporting language production. A model is proposed to account for how these systems congregate to produce language, featuring a dual-stream architecture of the semantic interface into item-based and item-independent semantic knowledge on the one hand, and a notion of the sensorimotor interface as a key component for the temporal tracking and verbal rehearsal of task-relevant information on the other. Avenues are also offered for enriching this architecture in future versions of the model. Finally, it is proposed that language is an "optimal" combination of these neurocognitive systems, enabling fast and cost-effective transfer of information at the systems level. This last point underpins evidence for the privileged status of language as a tool for adaptive thought and behavior, as well as some important features of brain evolution, development, and functional organization. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

73 Identification of 24-Month Cognitive Trajectories Among Clinical High Risk for Psychosis (CHR-P) Using Latent Class Mixture Modeling

Objective:Cohort studies demonstrate that people who later develop schizophrenia, on average, present with mild cognitive deficits in childhood and endure a decline in adolescence and adulthood. Yet, tremendous heterogeneity exists during the course of psychotic disorders, including the prodromal period. Individuals identified to be in this period (known as CHR-P) are at heightened risk for developing psychosis (~35%) and begin to exhibit cognitive deficits. Cognitive impairments in CHR-P (as a singular group) appear to be relatively stable or ameliorate over time. A sizeable proportion has been described to decline on measures related to processing speed or verbal learning. The purpose of this analysis is to use data-driven approaches to identify latent subgroups among CHR-P based on cognitive trajectories. This will yield a clearer understanding of the timing and presentation of both general and domain-specific deficits.Participants and Methods:Participants included 684 young people at CHR-P (ages 12–35) from the second cohort of the North American Prodromal Longitudinal Study. Performance on the MATRICS Consensus Cognitive Battery (MCCB) and the Wechsler Abbreviated Scale of Intelligence (WASI-I) was assessed at baseline, 12-, and 24-months. Tested MCCB domains include verbal learning, speed of processing, working memory, and reasoning &amp; problem-solving. Sex- and age-based norms were utilized. The Oral Reading subtest on the Wide Range Achievement Test (WRAT4) indexed pre-morbid IQ at baseline. Latent class mixture models were used to identify distinct trajectories of cognitive performance across two years. One- to 5-class solutions were compared to decide the best solution. This determination depended on goodness-of-fit metrics, interpretability of latent trajectories, and proportion of subgroup membership (&gt;5%).Results:A one-class solution was found for WASI-I Full-Scale IQ, as people at CHR-P predominantly demonstrated an average IQ that increased gradually over time. For individual domains, one-class solutions also best fit the trajectories for speed of processing, verbal learning, and working memory domains. Two distinct subgroups were identified on one of the executive functioning domains, reasoning and problem-solving (NAB Mazes). The sample divided into unimpaired performance with mild improvement over time (Class I, 74%) and persistent performance two standard deviations below average (Class II, 26%). Between these classes, no significant differences were found for biological sex, age, years of education, or likelihood of conversion to psychosis (OR = 1.68, 95% CI 0.86 to 3.14). Individuals assigned to Class II did demonstrate a lower WASI-I IQ at baseline (96.3 vs. 106.3) and a lower premorbid IQ (100.8 vs. 106.2).Conclusions:Youth at CHR-P demonstrate relatively homogeneous trajectories across time in terms of general cognition and most individual domains. In contrast, two distinct subgroups were observed with higher cognitive skills involving planning and foresight, and they notably exist independent of conversion outcome. Overall, these findings replicate and extend results from a recently published latent class analysis that examined 12-month trajectories among CHR-P using a different cognitive battery (Allott et al., 2022). Findings inform which individuals at CHR-P may be most likely to benefit from cognitive remediation and can inform about the substrates of deficits by establishing meaningful subtypes.

1 Neuromarker of Mind Wandering Predicts CSF-based Biomarkers of Amyloid and Tau Pathology

Objective:Mind-wandering—the spontaneous shift in attention away from the external task to internal thoughts (including daydreaming, fantasizing, rumination, and worrying)—is negatively associated with performance across a variety of tasks including the sustained attention to response task, the Stroop task, tasks of working memory, choice reaction time, visual search, as well as more ecologically related tasks like reading comprehension and mathematics. There has also been promising evidence suggesting a potential link between mind-wandering, functional connectivity of the canonical networks of the brain, and Alzheimer’s disease (AD). However, no study has directly examined the relationship between neural correlates of mind-wandering and AD pathogenesis. In prior work, our lab has identified a whole-brain, functional connectivity-based marker of mind-wandering—the mwCPM—which predicted response time variability in older adults. In this study, we sought to evaluate the ability of this mind wandering CPM, derived from response time variability, to predict CSF p-tau/Aß42 ratio in 289 older adults from the Alzheimer’s Disease Neuroimaging Initiative. We hypothesized that the combined mind-wandering model including functional connections that predict high mind-wandering and functional edges that predict stability in attention, would predict AD pathology.Participants and Methods:Resting-state functional MRI data from 289 older adults (147 healthy older adults, 111 individuals with mild cognitive impairment, and 31 older adults with AD) from the Alzheimer’s Disease NeuroImaging Initiative was analyzed for the current study. Participants were only included in the analyses if they had resting-state fMRI data, CSF measures of amyloid beta and tau pathology, and performance on cognitive composites of global cognition, episodic memory, and executive functioning. Using the well-established methodology of connectome-based predictive modeling, the mind-wandering model was applied to the resting-state fMRI data to predict CSF-based biomarker levels of p-tau and Aß42. Moreover, we also examined if this mind-wandering model predicted individual differences in composite measures of global cognition, episodic memory, and executive functioningResults:The high mwCPM model successfully predicted measured CSF p-tau/Aß ratios (high model: p = .137, p = .0196), controlling for mean framewise displacement. However, the combined network and the low MW network were not significant (combined model: p = .0731, p = .216; low model: p = -.0027, p = .960). We next examined the association between connectivity strengths of the high mwCPM and cognitive functioning in the domains of general cognition, episodic memory, and executive functioning. Connectivity strength in the high mwCPM—functional edges that were associated with high behavioral variability—were negatively associated with all three cognitive composites (global cognition: r = -.239, p &lt; .0001; episodic memory: r = -.208, p = &lt; .0001; executive functioning: r = -.178, p &lt; .0001).Conclusions:This study provides the first empirical support for a link between a neuromarker of mind-wandering and AD pathophysiology. Moreover, mind-wandering also has downstream consequential effects for key domains of cognitive functioning in older adults. Interventions targeted at reducing mind-wandering, particularly before the onset of AD pathogenesis, may make a significant contribution to the prevention of AD-related cognitive decline.

Emotion recognition in relation to tumor characteristics in patients with low-grade glioma.

Patients with low-grade gliomas (LGG) treated with surgery, generally function well and have a favorable prognosis. However, LGG can affect neurocognitive functioning. To date, little is known about social cognition (SC) in these patients, although impaired SC is related to social-behavioral problems and poor societal participation. Frontal brain areas are important for SC and LGG frequently have a frontal location. Therefore, the aim of the present study was to investigate whether emotion recognition, a key component of SC, was impaired, and related to general cognition, tumor location, laterality, tumor volume, and histopathological characteristics in patients with LGG, postsurgery, and before start of adjuvant therapy. A total of 121 patients with LGG were matched with 169 healthy controls (HC). Tumor location [including (frontal) subregions; insula, anterior cingulate cortex, lateral prefrontal cortex (LPFC), orbitofrontal-ventromedial PFC] and tumor volume were determined on MRI scans. Emotion recognition was measured with the Ekman 60 faces test of the Facial Expressions of Emotion-Stimuli and Tests (FEEST). Patients with LGG performed significantly lower on the FEEST than HC, with 33.1% showing impairment compared to norm data. Emotion recognition was not significantly correlated to frontal tumor location, laterality, and histopathological characteristics, and significantly but weakly with general cognition and tumor volume. Emotion recognition is impaired in patients with LGG but not (strongly) related to specific tumor characteristics or general cognition. Hence, measuring SC with individual neuropsychological assessment of these patients is crucial, irrespective of tumor characteristics, to inform clinicians about possible impairments, and consequently offer appropriate care.

General Anesthesia, Cognition, and Neurological Comorbidities

General anesthesia is a frequently employed medical intervention that facilitates the induction of a temporary state of unconsciousness, hence facilitating the execution of surgical procedures in patients. Nevertheless, the cognitive capabilities of patients with neurological comorbidities, such as epilepsy or dementia, may be a subject of worry when contemplating the impact of general anesthesia. Studies have indicated that individuals who have pre-existing neurological diseases may encounter negative consequences on their brain function when exposed to anesthesia. These consequences can manifest as a reduction in cognitive abilities or a worsening of their current coexisting medical conditions. Hence, it is imperative for healthcare practitioners to thoroughly assess the potential advantages and disadvantages of general anesthesia in individuals with neurological comorbidities. This evaluation should encompass exploring alternative methodologies or tailoring anesthetic management strategies to mitigate potential complications and enhance patients’ overall results.

Anti-inflammatory effects of icariin in the acute and chronic phases of the mouse pilocarpine model of epilepsy

Neuroinflammation mediated by microglia made a significant contribution in the pathophysiology of epilepsy. Icariin (ICA), a bioactive ingredient isolated from Epimedium, has been shown to present both antioxidant and anti-inflammatory properties. This study was to explore the potential therapeutic effects of icariin on mouse pilocarpine model of epilepsy and its underlying mechanisms in vivo and in vitro. To this end, we firstly measured the serum concentrations of the proinflammatory cytokines IL-1β and IL-6 from patients with temporal lobe epilepsy and found that patients with a higher seizure frequency showed correspondingly higher inflammatory reaction. Mouse pharmacokinetic study, transmembrane transportation assay, and cell viability assay collectively demonstrated that ICA was able to cross the blood-brain barrier and has good biocompatibility. The acute and chronic epilepsy models were next established in a pilocarpine mouse model of acquired epilepsy. Icariin has been identified that it could cross the blood-brain barrier and enter the hippocampus to exhibit therapeutic effects. ICA treatment dramatically promoted microglial polarization to the M2 phenotype in epilepsy mice both in the acute and chronic phases. Reduced release of M1-associated proinflammatory factors, such as IL-1β and IL-6, corroborates the altered glial cell polarization. Furthermore, ICA alleviated seizure intensity and mortality in acute phase epileptic mice. Models in the chronic group also showed improved general condition, cognition ability, and memory function after ICA treatment. Taken together, our research strongly suggested that icariin has the potential to treat epilepsy via inhibiting neuroinflammation by promoting microglial polarization to the M2 phenotype.

Социально-структурные аспекты глобализации: методологические основы исследования

The article examines the category of the global social structure and its position in the conceptual and categorical apparatus of modern sociological science. This category is characterized by a certain novelty and needs further theoretical development. The authors note and describe the concepts that form the basis of the society’s global social structure research from the perspective of the modern system approach, and consider its significance in the typology of social structures of society. A special place in the article is devoted to the levels of social structures, the study of theoretical concepts that constitute the foundation of methodological representations of the global social structure study. As methodological sources, the article uses works directly related to the concepts of global social structure and metastructure. The authors conduct a sociological analysis of the social system and social structure categories; identify the social structure levels according to the dialectics of individual, special and general cognition. The article discusses the possibilities of applying the main provisions of A. A. Bogdanov’s tectology as a method for sociological research of various modern social systems and structures types. The applicability of the globalization sociological apparatus within the framework of the sustainable development concept is considered. The study suggests that the global social structure should be considered in conjunction with new social formations, namely global social strata and institutions. However, but this requires further development of the conceptual and categorical apparatus.

Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder.

The Insulin-like growth factor 2 (IGF-2) has been recently proven to alleviate depressive-like behaviors in both rats and mice models. However, its potential role as a peripheral biomarker has not been evaluated in depression. To do this, we measured plasma IGF-2 and other members of the IGF family such as Binding Proteins (IGFBP-1, IGFBP-3, IGFBP-5 and IGFBP-7) in a depressed group of patients (n = 51) and in a healthy control group (n = 48). In some of these patients (n = 15), we measured these proteins after a period (19 ± 6 days) of treatment with antidepressants. The Hamilton Depressive Rating Scale (HDRS) and the Self-Assessment Anhedonia Scale (SAAS) were used to measure depression severity and anhedonia, respectively. The general cognition state was assessed by the Mini-Mental State Examination (MMSE) test and memory with the Free and Cued Selective Reminding Test (FCSRT). The levels of both IGF-2 and IGFBP-7 were found to be significantly increased in the depressed group; however, only IGF-2 remained significantly elevated after correction by age and sex. On the other hand, the levels of IGF-2, IGFBP-3 and IGFBP-5 were significantly decreased after treatment, whereas only IGFBP-7 was significantly increased. Therefore, peripheral changes in the IGF family and their response to antidepressants might represent alterations at the brain level in depression.

Long-term motor development after hypothermia-treated hypoxic-ischaemic encephalopathy

AimsTo describe longitudinal motor development in children treated with therapeutic- hypothermia (TH) due to neonatal hypoxic-ischaemic encephalopathy (HIE) and to explore motor functioning in early adolescence. Material and methodsChildren treated with TH due to HIE during 2007–2009, in Stockholm, participated in a prospective follow-up study. Motor development was assessed on four occasions, reported as percentiles and at mean ages. Alberta Infant Motor Scale was used at 0.35 years of age, Bayley Scales of Infant and Toddler Development-III at 2.1 years and Movement Assessment Battery for Children (MABC-2) at 7.3 and 11.1 years of age. MABC-2 Checklist was completed by parents at 7.3 and 11.1 years of age. General cognition was assessed using Wechsler Intelligence Scales for Children Fifth Edition (WISC-V). ResultsThirty-one percent (14/45) of the children had a motor score ≤ 15th percentile, indicating risk of motor difficulties at 11.1 years of age, and simultaneously the scores from parents of 52% (23/44), indicating risk of motor difficulties in the everyday context. These children had significantly lower motor percentile at 2.1 years of age, but within the normal range. Longitudinal motor development displayed a weak association with WISC-V Full Scale IQ (rs0.38, p = 0.013). ConclusionAmong survivors of hypothermia-treated HIE free of moderate/severe cerebral palsy, a third had MABC-2 scores indicating risk of motor difficulties at 11.1 years of age. As motor difficulties became more apparent over time, we suggest that children treated with TH due to neonatal HIE should be followed into at least middle school age.

Dietary consumption of beef and red meat: a scoping review and evidence map on cognitive outcomes across the lifespan.

Mixed evidence exists on the impact of beef consumption on cognition. The goal was to create an evidence map capturing studies assessing beef consumption and cognition to reveal gaps and opportunities in the body of literature. A scoping review was conducted to locate studies up to March 2022 using PubMed and backwards citation screening. Data were extracted by two independent reviewers with conflict resolution, and a database was created and made publicly available. Intervention and observational studies. Humans of any age, sex and/or health status, without moderate to severe cognitive impairment and/or abnormalities. Twenty-two studies were identified that quantified beef or red meat intake and assessed cognition. Six studies assessed beef intake, with the remaining studies describing intake of red meat that may or may not include beef. Nine articles described randomised controlled trials (RCT), mostly conducted in children. Thirteen described observational studies, primarily conducted on adults and seniors. The most common cognitive domains measured included intelligence and general cognition, and memory. The majority of controlled studies were rated with high risk of bias, with the majority of observational trials rated with serious or greater risk of bias. Red meat and beef intake and cognition is largely understudied. There is a significant lack of replication across study designs, populations, exposures and outcomes measured. The quality of the research would be considerably enhanced by focused assessments of beef intake (and not red meat in general) and specific cognitive domains, along with improved adherence to reporting standards.

First Episode Schizophrenia: Psychiatric and Cognitive Study for the Patients and Their First-degree Relatives

Background: severe and persistent mental condition Adults have a lifetime prevalence of schizophrenia that ranges from 0.4 to 1%. The purpose of this study was to compare the cognitive function of first-episode schizophrenic patients to that of multiple schizophrenic patients, as well as to examine cognitive function in patients with first-episode schizophrenia and the impact of treatment on first-degree relatives of the patient.&#x0D; Methods: The 200 participants in this cross-sectional case-control study were of both sexes and ranged in age from 18 to 50. There were five groups created for the subjects: Group I (n=50): Schizophrenia in its initial episode. Group II (n=50): Relatives of schizophrenia patients experiencing their first episode. Group III (n=50): Schizophrenia with multiple episodes. Healthy volunteers make up Group IV (n=50). Group V (n=36): Group I was followed up with one year following therapy.&#x0D; Results: Total IQ, attention, executive function, memory function, and social cognition were significantly different between patients and controls. First-degree relatives and the control group showed substantial differences in attention, executive function, and memory function. The Wisconsin Card Sorting Test (WCST) categories that were completed and the number of preservation errors, as well as the Trail Making Test (TMT) A and B, Mayer-Salovey-Caruso Perception and experiencing areas of emotional intelligence (MESCIT), mental control, logical memory, total number of digits, association learning, and visual reproduction are all measured by the Wechsler Memory Scale (WMS). Other than the perception branch and experiential region (social cognition), there was no statistically significant change in the overall IQ, WCST, Benton Visual Retention Test (BVRT), or MESCIT.&#x0D; Conclusions: In terms of general intelligence, attention, executive function, memory function, and social cognition, first episode patients outperformed many episode patients.